Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ampio Pharmaceuticals Inc AMPE

Healthcare
Ampio Pharmaceuticals, Inc. is a drug discovery and development company. The Company is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.

Recent & Breaking News (OTCPK:AMPE)

Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation

PR Newswire 12 days ago

Ampio Announces Voluntary Delisting and SEC Deregistration

PR Newswire March 25, 2024

Ampio Provides Update on Results from Pre-IND Enabling Studies

PR Newswire February 14, 2024

Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal Actions

PR Newswire January 11, 2024

Ampio Pharmaceuticals to Present at the Emerging Growth Conference

PR Newswire October 31, 2023

Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201

PR Newswire October 5, 2023

Ampio Pharmaceuticals to Present at the Emerging Growth Conference

PR Newswire September 26, 2023

Ampio Pharmaceuticals Announces Reverse Stock Split

PR Newswire August 31, 2023

Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stock

PR Newswire May 26, 2023

AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS

PR Newswire April 18, 2023

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Ampio Pharmaceuticals, Inc.

Newsfile February 7, 2023

AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS

PR Newswire January 17, 2023

Ampio Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards

PR Newswire December 27, 2022

Ampio Pharmaceuticals Announces NYSE American Removal of Trading Suspension

PR Newswire November 17, 2022

Ampio Pharmaceuticals Announces Fifteen-to-One Reverse Stock Split

PR Newswire November 8, 2022

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Ampio Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 17, 2022 - (NYSE: AMPE)

PR Newswire October 19, 2022

DEADLINE TODAY: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

Newsfile October 17, 2022

AMPE DEADLINE TODAY: ROSEN, A TOP RANKED FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action - AMPE

Newsfile October 17, 2022

FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

Accesswire October 17, 2022

Ampio Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 17, 2022 to Discuss Your Rights - AMPE

Newsfile October 16, 2022